Joseph K. Belanoff, Chief Executive Officer at CORCEPT THERAPEUTICS INC (CORT), sold 1,121,227 shares at $26.27 ($29.4M) on 2022-07-06, disclosed to the SEC on 2022-07-08.
Open-market sale of $29.4M CORT by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $26.21 | 451,189 | $11.8M | 40.2% |
| 2 | $26.27 | 279,908 | $7.4M | 25.0% |
| 3 | $26.27 | 279,908 | $7.4M | 25.0% |
| 4 | $26.26 | 55,111 | $1.4M | 4.9% |
| 5 | $26.26 | 55,111 | $1.4M | 4.9% |
| Total | $26.24 avg | 1,121,227 |
| $29.4M |
| 100% |
| Filing → |
| CORT | SELL | 2026-03-27 | $2.6M | — | Filing → |
| CORT | SELL | 2025-12-03 | $3.2M | — | Filing → |
| CORT | SELL | 2025-11-05 | $4.9M | — | Filing → |